DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Sparano JA, Zhao F, Martino S et al.
Ten year update of E1199: phase III study of doxorubicin-cyclophosphamide followed by paclitaxel or docetaxel given every 3 weeks or weekly in patients with axillary node-positive or high-risk node-negative breast cancer.
San Antonio Breast Cancer Symposium; 2014 S3-03
We do not assume any responsibility for the contents of the web pages of other providers.